Ziopharm Oncology to Announce Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on March 5

    NEXT STORY
    VBI Vaccines Provides Corporate Update, Outlook for 2019, and Year-End 2018 Financial Results
    PREV STORY
    ADMA Biologics to Present at Upcoming Investor Conferences
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Phase 1 Data for Flotetuzumab, MacroGenics’ CD123 x CD3 DART® Molecule, Presented at ESMO Congress 2017

    Acceptable tolerability observed in first-in-human study Encouraging initial anti-leukemic activity observed in relapsed/refractory AML ...

    author_avatar
    NASDAQ Market News

    Geron Reports Imetelstat Oral Presentation at European Hematology Association Congress

    Updated Clinical Data from Original Part 1 of IMerge in Myelodysplastic Syndromes (MDS) PresentedMENLO ...

    author_avatar
    NASDAQ Market News

    Kiadis Pharma announces €12 million private placement with a U.S. healthcare investor

    author_avatar
    NASDAQ Market News